Friday, October 11, 2024
10:20 AM EST – Ventripoint Diagnostics Ltd. : Has submitted its next generation of software and hardware, VMS+4.0, for approval under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. Ventripoint Diagnostics Ltd. (V.VPT ) shares were down $0.01 at 0.155.
Stocks in Play: Ventripoint Diagnostics Ltd. , Fri, 11 Oct 2024 10:27:06 EST